4.4 Article

PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion

期刊

ENDOCRINE PATHOLOGY
卷 30, 期 2, 页码 81-89

出版社

HUMANA PRESS INC
DOI: 10.1007/s12022-019-9573-8

关键词

Pituitary adenoma; PITX2; SNAIL1; Cavernous sinus; Invasion

向作者/读者索取更多资源

Although most pituitary neuroendocrine tumors (PitNETs) show benign behavior, a significant number of PitNETs exhibit an aggressive course including cavernous sinus (CS) invasion. To date, the cause of CS invasion has not been fully elucidated. In this study, we analyzed the relationship between CS invasion in PitNETs and the expression of PITX2 and SNAIL1, which are the transcription factors associated with the morphogenesis of pituitary gland. Sixty cases with non-functional PitNETs were classified into four types: type 1a, none of CS invasion and suprasellar expansion; type 1b, suprasellar expansion without CS invasion; type 2a, CS invasion without suprasellar expansion; and type 2b, CS invasion with suprasellar expansion. We analyzed the expression of PITX2 and SNAIL1 employing quantitative real-time polymerase chain reaction (qPCR) and immunohisto-chemistry. Other parameters such as mitotic count, Ki-67 index, and p53 expression were also analyzed, which were previously reported as potential tumor proliferative markers in PitNETs. PITX2 expression was significantly higher in PitNETs with CS invasion than PitNETs without CS invasion (P=0.019). Expression of SNAIL1 was significantly elevated in PitNETs with suprasellar expansion compared with PitNETs without suprasellar expansion (P=0.02). There was no apparent relationship between CS invasion and mitotic count, Ki-67 index, and p53 expression (mitotic count, P=0.11; Ki-67 index, P=0.61; p53, P=0.66). High PITX2 expression was observed in non-functional PitNETs with CS invasion, suggesting that PITX2 may be involved in CS invasion of PitNETs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Recent progress in the research of suicide gene therapy for malignant glioma

Ryota Tamura, Hiroyuki Miyoshi, Kazunari Yoshida, Hideyuki Okano, Masahiro Toda

Summary: Malignant glioma, a highly aggressive primary brain tumor, has poor prognosis and requires new therapeutic modalities. Suicide gene therapy has gained attention, with recent focus on using tumor-tropic stem cells as cellular delivery vehicles. This approach shows potential for effective treatment of malignant gliomas.

NEUROSURGICAL REVIEW (2021)

Article Medicine, General & Internal

Long-Term Clinical Outcome of First Recurrence Skull Base Meningiomas

Yuki Kuranari, Ryota Tamura, Noboru Tsuda, Kenzo Kosugi, Yukina Morimoto, Kazunari Yoshida, Masahiro Toda

JOURNAL OF CLINICAL MEDICINE (2020)

Article Oncology

Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma-a case series

Ryota Tamura, Yukina Morimoto, Kenzo Kosugi, Mizuto Sato, Yumiko Oishi, Ryo Ueda, Ryogo Kikuchi, Hideaki Nagashima, Shinobu Noji, Yutaka Kawakami, Hikaru Sasaki, Kazunari Yoshida, Masahiro Toda

BMC CANCER (2020)

Article Oncology

Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab

Ryota Tamura, Toshihide Tanaka, Yukina Morimoto, Yuki Kuranari, Yohei Yamamoto, Jun Takei, Yuichi Murayama, Kazunari Yoshida, Hikaru Sasaki

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Article Pathology

Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors

Ryota Tamura, Mizuto Sato, Yukina Morimoto, Kentaro Ohara, Kenzo Kosugi, Yumiko Oishi, Yuki Kuranari, Makoto Murase, Kazunari Yoshida, Masahiro Toda

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)

Article Pathology

Novel histopathological classification of meningiomas based on dural invasion

Makoto Murase, Ryota Tamura, Yuki Kuranari, Mizuto Sato, Kentaro Ohara, Yukina Morimoto, Kazunari Yoshida, Masahiro Toda

Summary: The depth and patterns of dural invasion in meningiomas were quantitatively evaluated, and it was found that the invasion patterns were associated with meningioma recurrence.

JOURNAL OF CLINICAL PATHOLOGY (2021)

Article Clinical Neurology

Quiescent and Activated Fibroblasts in Lateral Ventricular Meningioma With a Dura-like Membrane

Mizuto Sato, Ryota Tamura, Yukina Morimoto, Yumiko Oishi, Kazunari Yoshida, Masahiro Toda

Summary: This study found an association between activated fibroblasts and dura matere-like membrane capsules in LVMs. The characteristics of membranous structure in LVMs may differ depending on tumor size.

WORLD NEUROSURGERY (2021)

Review Biochemistry & Molecular Biology

Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis

Ryota Tamura

Summary: Neurofibromatosis is a neurocutaneous syndrome characterized by tumors in the nervous system, with NF1, NF2, and SWN as its three main types. While NF1 and NF2 have known genetic mutations and targeted therapies, the molecular mechanisms of SWN remain unclear and require further research.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Neurosciences

Histopathological Investigation of Dura-like Membrane in Vestibular Schwannomas

Yumiko Oishi, Ryota Tamura, Kazunari Yoshida, Masahiro Toda

Summary: The dura-like membrane (DLM) is an membranous structure arising from the dura mater adjacent to the internal auditory meatus that envelops some vestibular schwannomas (VSs). Recognition of DLM is important for preserving facial and cochlear nerves during tumor resection. The study found that the presence of DLM was associated with lower tumor resection volume, larger intratumoral vessel diameter, and higher intratumoral microvessel density.

BRAIN SCIENCES (2021)

Review Biochemistry & Molecular Biology

A Critical Overview of Targeted Therapies for Vestibular Schwannoma

Ryota Tamura, Masahiro Toda

Summary: Vestibular schwannoma is a benign tumor that originates from Schwann cells. Gamma knife radiosurgery is an accepted treatment, while targeted therapy and immunotherapy show potential for refractory cases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Neurosciences

Prolonged Survival and Restored Useful Life by Early Induction of Intrathecal Chemotherapy in a Patient with Leptomeningeal Carcinomatosis from Ovarian Cancer

Kento Takahara, Makoto Katayama, Ryota Tamura

Summary: Leptomeningeal carcinomatosis (LMC) is a rare but devastating complication of advanced cancer, more commonly caused by breast cancer, lung cancer, and melanoma. Treatment with intrathecal chemotherapy via Ommaya reservoir and radiation therapy has shown success in prolonging survival in patients with LMC from ovarian cancer.

BRAIN SCIENCES (2022)

Article Biotechnology & Applied Microbiology

Gene therapy using genome-edited iPS cells for targeting malignant glioma

Ryota Tamura, Hiroyuki Miyoshi, Kent Imaizumi, Masahiro Yo, Yoshitaka Kase, Tsukika Sato, Mizuto Sato, Yukina Morimoto, Oltea Sampetrean, Jun Kohyama, Munehisa Shinozaki, Atsushi Miyawaki, Kazunari Yoshida, Hideyuki Saya, Hideyuki Okano, Masahiro Toda

Summary: This study demonstrates the potential benefit of gene-edited induced pluripotent stem cells (iPSCs) for the treatment of invasive glioma stem cells (GSCs). Neural stem cells (NSCs) derived from CRISPR/Cas9-edited iPSCs expressing a suicide gene showed enhanced tumor-trophic migratory capacity and significant in vivo antitumor effects. The study also identified key signaling pathways and gene expressions associated with the efficacy of therapeutic iPSC-NSCs.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2023)

Review Biochemistry & Molecular Biology

Drug Repositioning for Refractory Benign Tumors of the Central Nervous System

Ryota Tamura

Summary: Drug repositioning is the process of identifying new therapeutic potentials for approved drugs and discovering new therapies for untreated diseases. It can save time and cost compared to de novo drug discovery. This article reviews the utility of drug repositioning for refractory benign tumors of the central nervous system.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Clinical Neurology

Anterior transpetrosal approach: experiences in 274 cases over 33 years. Technical variations, operated patients, and approach-related complications

Ryosuke Tomio, Takashi Horiguchi, Hamid Borghei-Razavi, Ryota Tamura, Kazunari Yoshida, Takeshi Kawase

Summary: The anterior transpetrosal approach (ATPA) has been used for surgery since 1985, and this study analyzed 274 cases performed from 1984 to 2017. Petroclival meningioma was the most common diagnosis. Modifications to the ATPA, such as zygomatic osteotomy, were used to decrease complications, but brain injury and CSF leak remained unresolved problems. Facial nerve damage decreased after 2010, but CSF leak incidence did not improve.

JOURNAL OF NEUROSURGERY (2022)

暂无数据